Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Effect of Azithromycin treatment on the microbial composition, functional dynamics and resistomes of endocervical, vaginal and rectal microbiomes of women in Fiji with Chlamydia trachomatis infection.

  • Read more about Effect of Azithromycin treatment on the microbial composition, functional dynamics and resistomes of endocervical, vaginal and rectal microbiomes of women in Fiji with Chlamydia trachomatis infection.

TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

  • Read more about TP53 Inactivation Confers Resistance to the Menin Inhibitor Revumenib in Acute Myeloid Leukemia.

In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer.

  • Read more about In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer.

MIR192 Upregulates GLP-1 Receptor and Improves Statin-Induced Impairment of Insulin Secretion.

  • Read more about MIR192 Upregulates GLP-1 Receptor and Improves Statin-Induced Impairment of Insulin Secretion.

Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements.

  • Read more about Synergistic RAS-MAPK and AKT Activation in MYC-Driven Tumors via Adjacent PVT1 Rearrangements.

De novo design of Ras isoform selective binders.

  • Read more about De novo design of Ras isoform selective binders.

C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis.

  • Read more about C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis.

Dose-dependent sensitivity of human 3D chromatin to a heart disease-linked transcription factor.

  • Read more about Dose-dependent sensitivity of human 3D chromatin to a heart disease-linked transcription factor.

Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL.

  • Read more about Haplotype editing with CRISPR/Cas9 as a therapeutic approach for dominant-negative missense mutations in NEFL.

Heart tube morphogenesis is regulated by segment-specific gene regulatory networks controlled by MEF2C.

  • Read more about Heart tube morphogenesis is regulated by segment-specific gene regulatory networks controlled by MEF2C.

Pagination

  • Page 1
  • Next page ››
Subscribe to bioRxiv : the preprint server for biology

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List